SL-15 人鼻咽癌細(xì)胞系BioVector? / SL-15 Human Nasopharyngeal Carcinoma Cell Line
- 價(jià) 格:¥99850
- 貨 號(hào):BioVector? SL-15
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號(hào))
手機(jī):18901268599
地址:北京
- 已注冊(cè)
BioVector? SL-15 人鼻咽癌細(xì)胞系 / SL-15 Human Nasopharyngeal Carcinoma Cell Line
通用定義 / General Definition:BioVector? SL-15 是一種源自人類鼻咽癌 (Nasopharyngeal Carcinoma, NPC) 的上皮細(xì)胞系。它是研究鼻咽癌生物學(xué)行為的重要體外模型之一。SL-15 細(xì)胞常被用于探索 NPC 的發(fā)病機(jī)制、腫瘤細(xì)胞的遷移與侵襲能力、以及對(duì)新型抗癌藥物(包括化療藥、靶向藥物及天然產(chǎn)物提取物)的敏感性評(píng)價(jià)。在鼻咽癌研究領(lǐng)域,SL-15 與 CNE-1、CNE-2 等細(xì)胞系共同構(gòu)成了研究東亞高發(fā)性鼻咽惡性腫瘤的基礎(chǔ)工具。
BioVector? SL-15 is an epithelial cell line derived from Human Nasopharyngeal Carcinoma (NPC). It serves as a significant in vitro model for investigating the biological characteristics of NPC. SL-15 cells are frequently employed to explore the pathogenesis of NPC, cell migration and invasion capabilities, and the sensitivity to novel anti-cancer agents, including chemotherapeutics, targeted drugs, and natural product extracts. In the field of nasopharyngeal cancer research, SL-15, along with lines like CNE-1 and CNE-2, forms the fundamental toolkit for studying this malignancy, which has a high incidence in East Asia.
BioVector? SL-15 技術(shù)說明書 (Technical Datasheet)
中文版說明書
1. 產(chǎn)品基本信息
產(chǎn)品名稱: BioVector? SL-15 人鼻咽癌細(xì)胞
組織來源: 鼻咽 (Nasopharynx)
疾病背景: 鼻咽癌 (NPC)
生長(zhǎng)特性: 貼壁生長(zhǎng)
細(xì)胞形態(tài): 上皮樣 (Epithelial-like)
2. 培養(yǎng)條件
基礎(chǔ)培養(yǎng)基: BioVector? RPMI-1640 或 DMEM 培養(yǎng)基
血清添加: 10% BioVector? 優(yōu)質(zhì)胎牛血清 (FBS)
培養(yǎng)環(huán)境: 37 攝氏度,5% CO2,飽和濕度
傳代比例: 1:3 至 1:4;建議在細(xì)胞匯合度達(dá)到 80% - 90% 時(shí)進(jìn)行傳代。
3. 細(xì)胞應(yīng)用
抗腫瘤藥物篩選: 評(píng)估小分子抑制劑對(duì) NPC 細(xì)胞增殖和凋亡的影響。
信號(hào)轉(zhuǎn)導(dǎo)研究: 分析調(diào)控鼻咽癌細(xì)胞惡性表型的關(guān)鍵信號(hào)通路(如 Wnt, NF-kB 等)。
放射增敏研究: 測(cè)試不同化合物對(duì) SL-15 細(xì)胞放射治療敏感性的增強(qiáng)作用。
4. 注意事項(xiàng)
STR 鑒定: 鑒于 NPC 細(xì)胞系歷史上存在交叉污染風(fēng)險(xiǎn),BioVector? 強(qiáng)烈建議定期進(jìn)行 STR 鑒定。
無菌操作: 嚴(yán)格遵循無菌技術(shù),防止支原體及其他微生物污染。
English Datasheet
1. General Product Information
Product Name: BioVector? SL-15 Human Nasopharyngeal Carcinoma Cell Line
Tissue Source: Nasopharynx
Disease Context: Nasopharyngeal Carcinoma (NPC)
Growth Properties: Adherent
Morphology: Epithelial-like
2. Culture Conditions
Basal Medium: BioVector? RPMI-1640 or DMEM Medium
Serum Supplement: 10% BioVector? Fetal Bovine Serum (FBS)
Incubation: 37 degrees Celsius, 5% CO2, Saturated Humidity
Subculturing: 1:3 to 1:4 ratio; subculture when cells reach 80% - 90% confluence.
3. Applications
Anti-tumor Drug Screening: Assessing the effects of small molecule inhibitors on NPC cell proliferation and apoptosis.
Signal Transduction: Analyzing key signaling pathways (e.g., Wnt, NF-kB) that regulate the malignant phenotype of nasopharyngeal cancer cells.
Radiosensitization: Testing the ability of various compounds to enhance the sensitivity of SL-15 cells to radiation therapy.
4. Key Usage Notes
Cell Authentication: Given the historical risks of cross-contamination among NPC cell lines, BioVector? strongly recommends periodic STR (Short Tandem Repeat) profiling.
Aseptic Technique: Maintain strict sterile procedures to prevent Mycoplasma and other microbial contaminations.
Note: SL-15 cells should be handled under Biosafety Level 2 (BSL-2) conditions. For optimal experimental results, BioVector? recommends the use of validated culture media and high-grade FBS to ensure consistent cell growth and phenotypic stability.
BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心
電話:400-800-2947
工作QQ/微信同號(hào):1843439339
網(wǎng)址
http://www.nedfriskphoto.com
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 SL-15 人鼻咽癌細(xì)胞系BioVector? / SL-15 Human Nasopharyngeal Carcinoma Cell Line 的詢問
- 公告/新聞





